Patents by Inventor Eldon Quinn Farnes

Eldon Quinn Farnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20230181497
    Abstract: The present invention provides an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose in an aqueous solution wherein said concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient that is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
    Type: Application
    Filed: July 18, 2022
    Publication date: June 15, 2023
    Inventors: Eldon Quinn Farnes, Mayssa Attar, Rhett M. Schiffman, Ching-Ming Chang, Richard S. Graham, Devin F. Welty
  • KETOROLAC COMPOSITIONS FOR CORNEAL WOUND HEALING
    Publication number: 20210315805
    Abstract: The present invention is directed to an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose which promotes epithelial wound healing in a patients cornea.
    Type: Application
    Filed: February 19, 2021
    Publication date: October 14, 2021
    Inventors: David A. Hollander, Linda Villanueva, Eldon Quinn Farnes, Mayssa Attar, Rhett M. Schiffman, Ching-Ming Chang, Richard S. Graham, Devin F. Welty
  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20200197336
    Abstract: The present invention provides an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose in an aqueous solution wherein said concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient that is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
    Type: Application
    Filed: March 2, 2020
    Publication date: June 25, 2020
    Inventors: Eldon Quinn Farnes, Mayssa Attar, Rhett M. Schiffman, Ching-Ming Chang, Richard S. Graham, Devin F. Welty
  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20160243078
    Abstract: The present invention provides an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose in an aqueous solution which provides increased visual acuity in users and wherein said concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient which is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
    Type: Application
    Filed: October 16, 2015
    Publication date: August 25, 2016
    Inventors: Eldon Quinn Farnes, Mayassa Attar, Rhett M. Schiffman, Chin-Ming Chang, Richard S. Graham, Devin F. Welty
  • KETOROLAC COMPOSITIONS FOR CORNEAL WOUND HEALING
    Publication number: 20130245088
    Abstract: The present invention is directed to an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose which promotes epithelial wound healing in a patients cornea.
    Type: Application
    Filed: April 6, 2011
    Publication date: September 19, 2013
    Applicant: ALLERGAN, INC.
    Inventors: David A. Hollander, Linda Villanueva, Eldon Quinn Farnes, Mayssa Attar, Rhett M. Schiffman, Chin-Ming Chang, Richard S. Graham, Devin F. Welty
  • KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
    Publication number: 20120196914
    Abstract: The present invention provides an aqueous ophthalmic solution comprising an effective amount of ketorolac which comprises carboxymethyl cellulose in an aqueous solution wherein said concentration of carboxymethyl cellulose is selected to provide an increased absorption of ketorolac in the eye of a patient that is at least 130% greater than the absorption of a comparative aqueous ketorolac ophthalmic solution having the same concentration of ketorolac.
    Type: Application
    Filed: April 13, 2012
    Publication date: August 2, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Eldon Quinn Farnes, Mayssa Attar, Rhett M. Schiffman, Chin-Ming Chang, Richard S. Graham, Devin F. Welty